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Abstract
Neurexin and neuroligin are transmembrane adhesion proteins that play an important role in organizing the neuronal synaptic
cleft. Our lab previously reported a method for imaging the trans-synaptic binding of neurexin and neuroligin called BLINC
(Biotin Labeling of INtercellular Contacts). In BLINC, biotin ligase (BirA) is fused to one protein while its 15-amino acid acceptor
peptide substrate (AP) is fused to the binding partner. When the two fusion proteins interact across cellular junctions, BirA
catalyzes the site-specific biotinylation of AP, which can be read out by staining with streptavidin-fluorophore conjugates.
Here, we report that BLINC in neurons cannot be reproduced using the reporter constructs and labeling protocol previously
described. We uncover the technical reasons for the lack of reproducibilty and then re-design the BLINC reporters and labeling
protocol to achieve neurexin-neuroligin BLINC imaging in neuron cultures. In addition, we introduce a new method, based on
lipoic acid ligase instead of biotin ligase, to image trans-cellular neurexin-neuroligin interactions in human embryonic kidney
cells and in neuron cultures. This method, called ID-PRIME for Interaction-Dependent PRobe Incorporation Mediated by
Enzymes, is more robust than BLINC due to higher surface expression of lipoic acid ligase fusion constructs, gives stronger and
more localized labeling, and is more versatile than BLINC in terms of signal readout. ID-PRIME expands the toolkit of methods
available to study trans-cellular protein-protein interactions in living systems.
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Introduction
Neurexins (NRX) are presynaptic adhesion proteins that bind
across the synaptic cleft to postsynaptic neuroligins (NLG). This
trans-cellular binding is believed to play a role in synapse
formation, specification, and/or stabilization [1]. To facilitate
the study of NRX-NLG biology, it would be desirable to have a
non-invasive method that reports on their binding in living cells.
A recent study [2], building upon the GRASP technology (GFP
Reconstitution Across Synaptic Partners) introduced earlier [3],
identifies synapses using GFP complementation of the NRX-
NLG interaction. A fragment of GFP is fused to the ectodomain
of NRX while the complementary GFP fragment is fused to the
ectodomain of NLG. Formation of a NRX-NLG adhesion
complex at synapses recombines the GFP fragments, and
fluorescence is restored an hour or more later. The primary
limitations of GRASP for NRX-NLG interaction detection are
that GFP recombination is irreversible [4] and GFP fluores-
cence is dim. The irreversibility can shift the equilibrium
between the complexed and non-complexed states of NRX-
NLG, and preclude dynamic reporting of NLG-NRX interac-
tions upon stimulation.
In 2010, we presented an alternative approach to image trans-
synaptic NRX-NLG interactions based on enzymatic biotinylation
of an acceptor peptide (AP) by E. coli biotin ligase (BirA, Figure 1A)
[5] (paper now retracted). In this report, AP was fused to NLG and
BirA was fused to NRX. When expressed in different but
contacting neurons, site-specific biotinylation, detected by staining
of live neurons with streptavidin-fluorophore conjugates, was
reported at synaptic contacts. This method was named BLINC, for
Biotin Labeling of INtercellular Contacts [5]. Since this publica-
tion, we have discovered that the work in this paper cannot be
reproduced. Here, we examine the technical reasons for irrepro-
ducibility, make changes in the BLINC constructs and protocols in
order to achieve successful BLINC labeling in neuronal cultures,
and then introduce an improved method for NRX-NLG contact
imaging based on lipoic acid ligase instead of biotin ligase
(Figures 1B–C).
Materials and Methods
Plasmids Summary
All genetic constructs used in this work are summarized in
Table S1. For each construct, the domain organization, BirA, AP,
LplA, or LAP insertion site, epitope tag, promoter, and vector are
given. The table also indicates which plasmids were used in each
figure. Constructs were prepared by standard restriction cloning
methods and QuikChange mutagenesis (Stratagene). Overlap
extension PCR was used to clone pCAG- BirA36-NRX3b and
pCAG-BirA272-NRX3b.
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HEK Cell Culture and Transfection
Human embryonic kidney 293T (HEK) cells were grown in
minimal essential medium (MEM, Mediatech) supplemented with
10% (v/v) fetal bovine serum (PAA Laboratories) at 37uC under
5% CO2. Cells were typically transfected at ,70% confluence
using Lipofectamine 2000 (Life Technologies) using the manufac-
turer’s suggested protocol. Cells for imaging were grown on
150 mm glass coverslips pre-coated with 50 mg/ml human
fibronectin (Millipore). Approximately 24 hours after transfection,
cells were lifted by trypsinization, co-plated at ,80% density, and
labeled for BLINC or ID-PRIME ,24 hours later.
Rat Hippocampal Neuron Culture and Lipofection
Sprague Dawley rat embryos were sacrificed at embryonic
day 18. Dissected hippocampal tissue was digested with papain
(Worthington) and DNaseI (Roche), then plated on 0.09–
0.12 mm thickness glass coverslips (Carolina Biological Supply)
in a 1:1 volume ratio of growth medium A and growth medium
B and cultured at 37uC under 5% CO2. Growth medium A is
MEM (Sigma) with L-glutamine (Sigma) supplemented with
10% (v/v) fetal bovine serum (PAA laboratories) and 2% (v/v)
B27 (Life Technologies). Growth medium B is Neurobasal
medium (Life Technologies) supplemented with 2% (v/v) B27
and 1% (v/v) GlutaMAX (Life Technologies). Glass coverslips
were pretreated with poly-D-lysine (Sigma) and mouse laminin
(Life Technologies). At 2 days in vitro, half of the spent culture
medium was replaced with fresh growth medium B. This
process was then repeated every 24 hours starting at 5 days
in vitro. Transfection by Lipofectamine 2000 was performed
between 5 to 11 days in vitro, using 1 mL Lipofectamine 2000
reagent per 1.91 cm2 well (less than the manufacturer’s
recommendation, to reduce toxicity).
Ethics Statement
All animals were housed, cared for, and experiments
conducted in accordance with the Massachusetts Institute of
Technology Committee on Animal Care guidelines (Assurance
# A-3125-01) as specifically approved as part of animal
protocol # 0910-076-13. Pregnant Sprague Dawley rats were
euthanized at embryonic day 18/19 using carbon dioxide
asphyxiation. Euthanasia was considered complete when animals
were unresponsive to tail pinch, according to the recommen-
dations of the Panel on Euthanasia of the American Veterinary
Medical Association (AVMA). After euthanasia, the thoracic
cavity was opened or cervical dislocation was carried out. The
rat embryos were removed from the uterus and decapitated to
remove the brain. No pain was expected under this protocol
because of the carbon dioxide used and the under-developed
sensory nervous systems of the pups.
Figure 1. Scheme showing BLINC and ID-PRIME methods for imaging trans-cellular protein-protein interactions. (A) In Biotin Labeling
of INtercellular Contacts (BLINC), protein A is genetically tagged with the 35 kDa E. coli biotin ligase (BirA) on the extracellular side. Protein B is
genetically tagged with a 15-amino acid acceptor peptide (AP) for BirA. When proteins A and B interact, BirA ligates biotin onto protein B, which can
be detected using a monovalent streptavidin-fluorophore conjugate [23]. (B) In Interaction-Dependent PRobe Incorporation Mediated by Enzymes
(ID-PRIME), protein A is genetically tagged with a 38 kDa mutant of E. coli lipoic acid ligase (*LplA=W37A, T57I, F147L, H267R mutant of LplA) on its
extracellular side. Protein B is genetically tagged with a 13-amino acid ligase acceptor peptide (LAP) for LplA. When proteins A and B interact, *LplA
ligates lipoic acid onto protein B, which can be detected using an antibody-fluorophore conjugate. (C) Alternative ID-PRIME detection using picolyl
azide ligation onto protein B. Ligated azide can be detected by copper-catalyzed click chemistry with alkyne-fluorophore conjugates [7].
doi:10.1371/journal.pone.0052823.g001
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Neuron Nucleofection Using the Rat Neuron
Nucleofector Kit (Lonza)
Dissociated neurons were suspended in 100 mL nucleofection
solution provided by the kit at a density of 1–1.56107 cells/mL,
and mixed with 1 mg of each plasmid construct, then transferred
into a nucleofection cuvette and nucleofected with the O-003
program. Cells were rescued in growth medium A (pre-warmed to
37uC), then plated onto poly-D-lysine treated glass coverlips
(12 mm diameter) at a density of 150,000 cells per 1.9 cm2. We
note that the homemade nucleofection solution reported in [5]
works for some mammalian cell lines, but causes neuron sickness
in our hands.
BLINC Labeling of HEK and Neuronal Cultures
BLINC labeling was typically carried out 24 hours after co-
plating for HEK cell cultures, or 5–12 days after co-plating for
neuron cultures. Cells were incubated in growth medium B
containing 20 mM biotin (gift from Tanabe USA), 500 mM ATP,
and 1.25 mM magnesium acetate for 5–15 min. at 37uC. Cells
were then rinsed three times with Tyrode’s buffer (145 mM NaCl,
1.25 mM CaCl2, 3 mM KCl, 1.25 mM MgCl2, 0.5 mM
NaH2PO4, 10 mM glucose, 10 mM HEPES, pH 7.4) and
subsequently stained with wild-type streptavidin-Alexa Fluor 647
(AF647) or monovalent streptavidin-AF647 conjugate [6] in
Tyrode’s buffer supplemented with 0.5% (w/v) vitamin-free casein
(MP Biomedicals) for 5 min. at 37uC. Cells were rinsed three more
times with Tyrode’s buffer before imaging.
Alternatively, HEK cells were treated with 5 mM biotin-AMP
[6] for 2 min. at 37uC instead of biotin plus ATP (in Figure 2B).
We found that labeling with biotin-AMP was suitable for HEK
cells but not for neurons, as it produced high background (Figure
S6).
Biotinylation of total surface AP using purified enzyme was
performed in the same way except that 1 mM biotin ligase [6] was
also added during the first labeling step.
ID-PRIME Labeling of HEK and Neuronal Cultures
ID-PRIME labeling was typically carried out 24 hours after co-
plating for HEK cell cultures, 5–12 days after co-plating for
nucleofected neuron cultures, or 1–2 days after sequentially
lipofecting neurons. Cells were treated with Tyrode’s buffer
containing 500 mM ATP, 1.25 mM magnesium acetate, and
either 100 mM DL-a-lipoic acid (Alexis Biochemicals) or 100 mM
picolyl azide [7] for 15–20 min. at 37uC.
To detect lipoic acid, cells were rinsed three times in Tyrode’s
buffer and subsequently stained with a 1:200 dilution of rabbit
anti-lipoic acid polyclonal antibody (Calbiochem) for 5 min. in the
same buffer. Cells were again rinsed three times, followed by a
1:300 dilution of goat anti-rabbit secondary antibody AF647
conjugate (Life Technologies) for the same time in the same buffer.
Cells were imaged live after three further rinses.
To detect picolyl azide on HEK cells, cells were rinsed three
times in Tyrode’s buffer and treated with 50 mM CuSO4, 2.5 mM
sodium ascorbate, 20 mM alkyne-AF647 conjugate (Life Technol-
ogies), 250 mM THPTA ligand [8] and 100 mM 4-hydroxy-
2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPOL, Calbiochem) in
the same buffer for 5 min. at room temperature. Ligand bound
Cu(I) complexes were pre-formed by mixing the CuSO4, sodium
ascorbate and THPTA, and incubating at room temperature for
10 min., before the alkyne and TEMPOL were added. Cells were
rinsed three times further, then fixed with 4% (v/v) formaldehyde
in a pH 7.0 buffer containing 0.12 M sucrose for 15 min. at room
temperature before imaging.
Azide detection in neurons was performed after fixation (Figure
S9). After picolyl azide ligation on living neurons as described
above, neurons were fixed with 4% (v/v) formaldehyde in Tyrodes
buffer, then blocked in Tyrode’s buffer supplemented with 0.5%
(w/v) casein for one hour. Cells were treated with 1 mM CuSO4,
2.5 mM sodium ascorbate, 5 mM alkyne-AF647 conjugate,
100 mM TBTA ligand [8] and 100 mM TEMPOL in the same
buffer for one hour at room temperature. Ligand bound Cu(I)
complexes were pre-formed by mixing the CuSO4, sodium
ascorbate and TBTA, and incubating at room temperature for
10 min., before the alkyne and TEMPOL were added. Cells were
imaged after three further rinses.
Immunofluorescence Detection of BirA and LplA Fusion
Constructs in HEK and Neuronal Cultures
For live-cell immunofluorescence detection, cells were incubat-
ed with a 1:200 dilution of either a mouse anti-c-Myc antibody
(Calbiochem) or a rabbit anti-HA antibody (Rockland) in Tyrode’s
buffer supplemented with 0.5% (w/v) casein for 15 min. at 37uC.
Cell were rinsed three times with Tyrode’s buffer, and subse-
quently stained with the corresponding secondary antibody: goat
anti-mouse-AF568 conjugate or goat anti-rabbit-AF568 conjugate
(Life Technologies) in the same buffer. Cells were rinsed three
times with Tyrode’s buffer before imaging live at room temper-
ature.
For immunofluorescence detection on fixed cells, samples were
fixed with 4% formaldehyde in Tyrode’s buffer, then permeabi-
lized with methanol at 220uC. Cells were blocked for one hour in
Tyrode’s buffer supplemented with 0.5% (w/v) casein, followed by
primary antibody detection for one hour in the same buffer. A
1:200 dilution of one of the following antibodies was used: mouse
anti-c-Myc antibody (Calbiochem), rabbit anti-HA antibody
(Rockland), or mouse anti-FLAG M2 antibody (Agilent). Cells
were then rinsed three times with Tyrode’s buffer and subse-
quently stained with the corresponding secondary antibody: goat
anti-mouse-AF488 conjugate, goat anti-rabbit-AF488 conjugate,
or goat anti-rabbit-AF568 conjugate (Life Technologies). Cells
were rinsed three times further with Tyrode’s buffer before
imaging.
Confocal Fluorescence Microscopy
Neuron cultures placed in Tyrode’s buffer or HEK cells placed
in Dulbecco’s phosphate buffered saline (Gibco) were imaged
using a Zeiss AxioObserver.Z1 inverted confocal microscope with
a 40X oil-immersion objective. The microscope was equipped
with a Yokogawa spinning disk confocal head, a Quadband notch
dichroic mirror (405/488/568/647 nm), and 405 (diode), 491
(DPSS), 561 (DPSS), and 640 nm (diode) lasers (all 50 mW). BFP
(405 nm laser excitation, 445/40 emission filter), GFP/Venus/
AF488 (491 nm laser excitation, 528/38 emission filter), dsRed/
tdTomato/AF568 (561 nm laser excitation, 617/73 emission
filter), AF647 (640 nm laser excitation, 700/75 emission filter),
and DIC images were collected using a Cascade II:512 camera
and processed using SlideBook software version 5.0 (Intelligent
Imaging Innovations). Acquisition time ranged from 10–2000
milliseconds. Neuron images in Figures S4 and S5 were projection
summations from 0.5 mm-step optical stacks spanning 3.5 mm total
depth.
Quantification of Lipoic Acid ID-PRIME Sensitivity in
Neurons
Analysis was performed on 10 fields-of-view using the SlideBook
software. For each field-of-view, one binary mask was created for
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each of the two fluorescent protein transfection markers, Venus
and tdTomato. The two masks were then intersected to create an
intersection mask, which ranged from 26 to 172 puncta or oblong
segments (totaling 741 from 10 fields-of-view). Maximum lipoic
acid ID-PRIME pixel intensity was tabulated for the 741 puncta
or segments, and those with ID-PRIME signal-to-noise ratio
greater than 3:1 were tallied, giving 38%. If the signal-to-noise
ratio requirement was relaxed to 2:1, then 54% of Venus/
tdTomato overlaps were positive for ID-PRIME signal. Noise was
defined as the averaged ID-PRIME intensity on three non-
transfected cells. Microscope instrument noise, defined as the ID-
PRIME intensity on an area of the glass coverslip with no cell
coverage, was subtracted from both signal and noise before the
signal-to-noise ratio was calculated.
Chemicals and Reagents
The synthesis and characterization of biotin-AMP is described
in Methods S1. ID-PRIME reagents for picolyl azide labeling are
described in reference [7]. All chemicals were purchased from
Sigma-Aldrich unless otherwise specified.
Additional experimental methods can be found in Methods S1.
Results
BLINC in HEK cells
We started by applying the constructs from the 2010 work [5] in
human embryonic kidney 293T (HEK) cells (Figure 2). Two pools
of HEK cells were separately transfected with the BirA64-NRX1b
fusion (numbering indicates the BirA insertion site – at amino acid
64 of the immature NRX1b protein in this case) and the AP-
NLG1 fusion. The two HEK populations were then resuspended,
plated together, and allowed to form contacts over 24 hours.
Trans-cellular biotinylation was initiated with the addition of
biotin-AMP ester [5] for 2 min. Sites of AP biotinylation were
detected on living cells by staining with streptavidin-AF568
conjugate (Figure 2A). Images in Figure 2B show biotinylation
sites (BLINC signal) localized to NRX-NLG contacts, as indicated
by the YFP and BFP co-transfection markers. AP-NLG1-
expressing cells not contacting BirA cells were not labeled.
To test if BLINC labeling was interaction-dependent, we
introduced a point mutation (D137A) in NRX to abolish Ca2+
binding [9] and therefore eliminate trans-interaction with NLG1.
Figure 2B shows that the mutant construct, BirA64-NRX1b
(D137A), gave almost no detectable BLINC staining at contact
sites with AP-NLG1-expressing cells. As a positive control, we used
Figure 2. BLINC for imaging neurexin-neuroligin interactions in HEK cells. (A) Scheme showing the BLINC experimental protocol. Two
pools of HEK cells were separately transfected with BirA64-NRX1b plus YFP, or AP-NLG1 plus BFP. The pools were then mixed and allowed to form
contacts over 24 hours. BLINC labeling was performed with 10 mM biotin-AMP for 2 minutes (note that biotin+ATP was used instead for neuron
cultures in other figures, for reasons explained in Figure S6). Biotinylated AP sites were detected by live-cell staining with streptavidin-AF568 for 5
minutes. (B) BLINC imaging results. Controls are shown with a D137A mutation in BirA-NRX to abolish its interaction with NLG (rows 2 and 4), and
1 mM exogenous BirA added during the biotin-AMP step to label total cell surface AP-NLG1 (rows 3 and 4). When a NLG-expressing cell apposes a
NRX-expressing cell, BLINC signal is localized at contact sites (thin arrow heads, row 1). The same phenomenon was observed when exogenous BirA
was added to label the total NLG pool (thick arrow heads, row 3). All scale bars, 10 mm.
doi:10.1371/journal.pone.0052823.g002
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exogenous BirA (purified BirA enzyme added to the cell media) to
biotinylate the total surface pool of AP-NLG1, regardless of its
proximity to a BirA-NRX1b-expressing cell. The third row in
Figure 2B shows streptavidin staining of all AP-NLG1 expressing
cells, not only those in contact with BirA-NRX1b-expressing cells.
Interestingly, for blue cells in contact with green cells, the
streptavidin signal was still localized to cell-cell contact sites,
suggesting that when NRX and NLG expression levels are
matched, their binding affinity is strong enough to aggregate the
total surface protein pools at these contact regions. A similar
control with BirA-NRX1b (D137A)-expressing cells also showed
labeling of all AP-NLG1-expressing cells by exogenous BirA
(fourth row), but the streptavidin signal was not localized to
contact sites between green and blue cells. We believe that AP-
NLG1 distributes evenly around the perimeter of the transfected
cell because the NRX1b (D137A) mutant is unable to trap AP-
NLG1 at contact sites. From this experiment, we conclude that
NRX-NLG BLINC is robust and reproducible in HEK cells.
Unfortunately, we found that this was not the case in neuron
cultures. After many unsuccessful efforts to reproduce neuron
BLINC using the previously described NRX and NLG fusion
constructs and protocols [5], we decided to systematically examine
the fundamental aspects of the system.
Problems with the CMV-AP-NLG1 Construct from
Reference [5]
The design of the BLINC reporter system is such that AP and
BirA fusions must be introduced into separate but contacting cells.
HEK cells can be separately transfected, then lifted and replated
together, but neurons cannot be replated without damaging their
delicate processes and synapses. Therefore, it is necessary to
transfect them immediately after dissociation, while they are still in
suspension, and then plate them together thereafter. We previ-
ously opted for nucleofection-type transfection [5], because it is
compatible with suspended neurons, gives high transfection
efficiencies (necessary in order to see a reasonable number of
overlapping BirA- and AP-containing processes), and eliminates
the possibility of plasmid overlap, where BirA and AP fusions
express together in the same neuron.
We first examined the expression of BLINC constructs in
neurons by introducing the AP-NLG1 construct alone, using
nucleofection, into suspended hippocampal neurons at 0 days
in vitro (DIV0). Neurons were then plated, and five days later (since
previous experiments were all reported at DIV5 and DIV16 [5]),
we checked for expression by performing exogenous biotinylation
with purified BirA added to the culture medium. This assay is
expected to give a much stronger signal than any BLINC
experiment, because BirA is provided in great excess, and total
AP rather than just synaptic AP will be biotinylated. Figure S1
shows that no biotinylation was detected. We also found that
biotinylation was undetectable at DIV12. We were unable to
check at DIV16, because in order to see overlapping transfected
processes at DIV5, it was necessary to plate neurons at a high
initial density. As a result, neurons were often dense and unhealthy
at DIV16, making it difficult to distinguish specific biotinylation
from non-specific binding of streptavidin conjugates to unhealthy
cells. This published AP-NLG1 construct [5] used a CMV
promoter, which, according to previous reports, may give
inconsistent [10] and activity-dependent expression in transiently
transfected neuron cultures [11]. We therefore created an identical
construct driven by the CAG promoter [12] (CMV enhancer/
chicken b-actin) instead. This promoter has been used previously
for strong transgene expression in neurons [13,14]. Using CAG-
AP-NLG1, we were able to detect weak but specific biotinylation
in some neurons at DIV5 and DIV12 (Figure S1).
In another effort to improve the signal, we used a construct with
three tandem AP tags: CAG-3xAP-NLG1. Figure S1 shows that
exogenous biotinylation of neurons nucleofected with this
construct produced signal well above background and specific to
transfected cells, at both DIV5 and DIV12. All these comparisons
were performed in parallel under identical conditions. We
conclude that the CAG rather than CMV promoter was essential
to give long-lasting (.5 day) expression of this fusion construct in
transiently transfected neuron cultures, and the 3xAP rather than
1xAP tag on NLG was necessary to give streptavidin signal above
background in the majority of neurons at both DIV5 and DIV12.
The previous CMV-AP-NLG1 [5] construct lacked both persistent
expression and detectability above background, which explains
why it cannot be successfully used for BLINC in neurons.
Problems with the CMV-BirA-NRX1b Construct from
Reference [5]
We next turned our attention to the BirA-NRX fusion
construct. We introduced the previously published construct,
CMV-BirA64-NRX1b [5], by nucleofection into DIV0 hippocam-
pal neurons. Figure S2 shows that expression was not detected by
anti-c-Myc staining at both DIV5 and DIV12, although positive
controls with the same construct introduced one day before
labeling, by lipofection instead, were detectable.
We reasoned again that the CMV promoter could be part of the
problem, so we switched to a CAG promoter. Figure S3 shows that
CAG-BirA-NRX could be detected 4 days after lipofection of
neuron cultures whereas CMV-BirA-NRX could not. Based on
these experiments, we conclude that the CAG promoter is
essential to give persistent expression of this construct as well,
and the previously published CMV-BirA64-NRX1b [5] was
undetectable in neuron cultures five days after its introduction
by nucleofection. This explains why it cannot be successfully used
for BLINC in neurons.
New BirA Fusion Constructs
Using the improved CAG-BirA-NRX1b and CAG-3xAP-
NLG1 constructs that give persistent expression in neurons after
nucleofection, we attempted BLINC in neurons again, but were
still unsuccessful. Based on the images in Figure S3, we suspected
that part of the problem might be the poor trafficking of the BirA-
NRX fusion to the cell surface and to synapses; the majority of it
appeared to be intracellular and localized to the cell body rather
than distal processes. Indeed, immunofluorescence staining in
HEK cells (Figure S4C) showed that BirA64-NRX1b was mostly
trapped in the secretory pathway compared to c-Myc-LAP-
NRX1b (tag size 35 kD vs. 2.6 kD), suggesting that the large BirA
tag disrupted trafficking, and that its insertion site would have to
be optimized. Previous studies have inserted large tags, such as
fluorescent proteins, into the cytosolic tail of NRX [15,16] or into
its stalk domain [17,18], an extracellular region proximal to the
transmembrane segment.
We wondered if moving the BirA tag to different locations
might improve the surface targeting of our NRX fusion. We
prepared two new extracellular fusions of BirA to the NRX3b
gene. NRX3b is in many ways functionally interchangeable with
NRX1b; the two isoforms display similar endogenous localization
in neurons, possess similar trans-cellular binding affinity to NLG1
[19], and their crystal structures can be overlaid without significant
differences [19,20]. Figure S4C shows immunofluorescence
staining of BirA36-NRX3b (N-terminal fusion, after signal peptide)
and BirA272-NRX3b (stalk domain fusion), compared to HA-
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NRX3b, in HEK. Again, the BirA fusions were impaired in their
surface targeting compared to HA-NRX3b, where the latter was
predominantly localized to the cell surface. We also prepared a
BirA fusion to NLG1 at its N-terminus after the signal peptide
(BirA48-NLG1) and found that it too was largely trapped inside the
cell compared to HA-AP-NLG1 (tag size 35 kD vs 2.9 kD) (Figure
S4C).
Nevertheless, we tested our three new BirA fusion constructs in
neurons. Figure S4D shows live-cell immunostaining of DIV12
neurons transfected with each construct. HA-NRX3b produced a
very strong signal specific to transfected neurons. BirA36-NRX3b
and BirA272-NRX3b were much weaker, but still detectable above
background. In contrast, surface expression of BirA48-NLG1 was
undetectable. Figure S4E shows the same experiment but with
immunofluorescence staining performed after neuron fixation to
detect total protein pools. From these images it wa apparent that
HA-NRX3b and AP-NLG1 proteins could be found in distal
processes, while the BirA fusions were predominantly localized to
the cell bodies. We concluded that while none of our fusion sites
tolerate the 35 kD BirA tag well, the NRX fusions are better than
the NLG fusion, so we proceeded to try BLINC experiments with
these.
BLINC in Neurons with New BirA and AP Fusion
Constructs
First, we verified that both BirA36-NRX3b and BirA272-NRX3b
gave detectable and localized trans-cellular BLINC labeling with
3xAP-NLG1 in HEK cultures (data not shown), demonstrating
that they are functionally competent. Then we performed a
BLINC experiment in hippocampal neurons, introducing each
construct into separate pools of suspended DIV0 neurons by
nucleofection. Figure 3A shows that whereas BirA272-NRX3b
produced BLINC labeling at sites of overlap with 3xAP-NLG1-
expressing neurons (indicated by overlap of green and blue
transfection markers), BirA36-NRX3b did not. This trend was
observed across .15 fields of view in this experiment. The
observation that the site of BirA insertion into the extracellular
domain of NRX3b influenced BLINC sensitivity is interesting in
light of the fact that no difference in signal between these two
constructs was seen in HEK cultures (data not shown). Perhaps the
presence of endogenous NRX interaction partners in neurons
alters NRX’s conformation and decreases the steric accessibility of
fused BirA36, but not BirA272. The immunofluorescence controls
in Figure S4D show that the difference in BLINC outcomes in
neurons cannot be explained by a difference in surface expression
levels for BirA36-NRX3b versus BirA272-NRX3b.
We noticed that the BLINC signal in neurons was strongest at
sites of overlap between transfected cells, but streptavidin staining
was also detected at non-overlapping regions on the 3xAP-NLG1-
expressing cell (Figure 3A), suggesting that AP-NLG biotinylated
in trans by BirA could subsequently diffuse away from the site of
interaction. This contrasted with our observations in HEK cells,
where the BLINC signal was tightly localized to cell-cell contacts
and not diffusive (Figure 2B). We hypothesized that this
discrepancy in localization of BLINC signal resulted from a
difference in BirA:AP stoichiometry in these two experimental
configurations. Since the insertion of BirA into NRX3b strongly
impeded NRX3b trafficking to the surface of neurons while AP-
NLG1 did not have an apparent trafficking defect (Figure S4D–E),
there was probably insufficient BirA-NRX3b to anchor biotiny-
lated 3xAP-NLG1, and the latter could diffuse away from the
contact site after biotinylation. This explanation is supported by
our observations in a mixed culture experiment, where HEK cells
expressing BirA272-NRX3b were plated on top of hippocampal
neurons expressing 3xAP-NLG1 (Figure 3B). Here, the resulting
BLINC signal tightly localized to contact sites and did not diffuse
outward. We believe this is because the quantity of BirA-NRX3b
presented on the surface of the overlaid HEK cell was much
higher than that presented on the surface of an overlaid neuron,
and therefore anchoring of the biotinylated 3xAP-NLG1 pool
could occur. Using this mixed culture assay, we also performed a
negative control with the non-interacting D137A mutant of NRX
and observed an absence of BLINC signal (Figure 3B).
Another feature of our BLINC signal in neurons (Figure 3A) is
that it is clearly not synaptic. Apposing neurons differentially
expressing the transgenic NRX and NLG fusions sometimes
‘‘zipped up’’ along one another’s processes, establishing large
zones of contact that were clearly not synapses. This is likely an
overexpression artifact. Interestingly, when neurons were trans-
fected with either BLINC construct alone, the constructs displayed
good overlap with pre- and post-synaptic markers (Figure S5), but
in a trans experiment, the affinity of the overexpressed fusion
constructs for one another greatly perturbed neuron morphology.
Optimization of BLINC Labeling Reagent
Since BirA has a higher affinity for the biotin-AMP interme-
diate than ATP [21], biotin-AMP can be supplied at micromolar
concentrations and still produce labeling signal comparable to
millimolar concentrations of ATP (+20 mM biotin) [6]. Initially, as
per the reported protocol [5], we attempted BLINC labeling in
neurons using biotin-AMP in place of biotin+ATP (Figure S6).
This option is less likely to activate endogenous purine receptors
on neurons and cause toxicity [22]. We observed, however, that
even 2.5 mM biotin-AMP resulted in much higher background
fluorescence on neurons than 20 mM biotin +1 mM ATP (Figure
S6). Higher biotin-AMP concentrations worsened the background
without increasing the BLINC signal. This problem was not
observed in BLINC experiments in HEK cells (Figure 2B), so we
surmise that the high-energy biotin-AMP reagent was covalently
reacting with nucleophiles on polylysine/laminin-coated cover-
slips. Our observations are inconsistent with the previous BLINC
study [5], in which 10 mM biotin-AMP was used without
detectable background. We note, however, that biotin-AMP can
be used successfully for biotinylation of total surface AP-NLG1
pools on neurons, as in reference [23], because the signal is so
much stronger than BLINC signal that it can be clearly detected
above the biotin-AMP-related background.
NRX-NLG BLINC in Neurons is not Robust
Even with our improvements to the BLINC reporter constructs
and labeling protocol, we found that BLINC labeling in neurons
was not robust. BLINC signal intensity varied from nucleofection
to nucleofection and sometimes was not detectable at all. We
believe this is a consequence of variations in BirA-NRX surface
expression levels – sometimes it fell below the threshold necessary
to produce detectable labeling signal. We conclude that BLINC in
its current form can be a powerful and robust tool for imaging
NRX-NLG interactions in HEK cultures (as in Figure 2B) and in
HEK-neuron mixed cultures (as in Figure 3B), but the technology
in its current form is too unreliable in pure neuron cultures. For
this reason, we turned our attention to an alternative methodology
for NRX-NLG contact imaging in neurons.
ID-PRIME for NRX-NLG Interaction Imaging
Our lab has previously developed a suite of methods for
targeting chemical probes to specific proteins in living cells using
engineered mutants of E. coli lipoic acid ligase (LplA). These
methods are collectively called ‘‘PRIME’’, for PRobe Incorpora-
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tion Mediated by Enzymes [7,24–27]. PRIME works in a similar
way to BirA-mediated biotinylation, with the ligase catalyzing
covalent conjugation of a small molecule to a recognition peptide
(the Ligase Acceptor Peptide, or LAP), but our engineering of the
LplA active site has made it possible to conjugate a wide range of
chemical structures besides lipoic acid, including fluorophores
[24], photocrosslinkers [26], and functional group handles [27].
We have also found that the LplA/LAP pair can be used for
detection of cytosolic protein-protein interactions by ID-PRIME
(Interaction-Dependent PRIME), when the affinity of LAP for
LplA is tuned such that probe ligation occurs only when the
proteins to which LplA and LAP are fused interact [28]. We
wondered if the LplA/LAP pair could be used for detection of
intercellular protein-protein interactions in a manner analogous to
BLINC, as shown in Figures 1B–C.
There were a few considerations before we could attempt such
an experiment. First, we previously observed that LplA and its
mutants have high activity in the mammalian cytosol, but the
activity drops for unknown reasons when LplA is targeted to the
secretory pathway or the cell surface [24]. Separate efforts in our
lab have produced, using yeast display evolution, a quadruple
mutant of LplA with higher activity in the secretory pathway and
on the cell surface [29]. Second, we considered which LAP
sequence to use: the regular, high affinity sequence used for most
PRIME experiments with a KM of 13 mM [30], or the lower
affinity sequence used for intracellular ID-PRIME with a KM
Figure 3. BLINC for imaging neurexin-neuroligin interactions in neuron cultures and in HEK-neuron mixed cultures. (A) BLINC
labeling of pure neuron cultures. Two pools of hippocampal neurons were separately nucleofected at DIV0 with BirA-NRX plus a membrane
tdTomato marker (shown in blue), or 3xAP-NLG1 plus a Venus marker (shown in green). For the top row, the BirA36-NRX3b construct was used, and
for the bottom row the BirA272-NRX3b construct was used. All constructs had CAG promoters. Labeling was performed at DIV5 with biotin+ATP for 15
minutes, followed by monovalent streptavidin-AF647 detection for 5 minutes. Confocal images of live neurons showed no detectable BLINC signal for
the BirA36-NRX3b fusion across 10 fields of view in which Venus- and Tomato-expressing neurons were observed to be crossing. For the BirA272-
NRX3b fusion (bottom row), BLINC signal was detected in 5 out of 10 such fields of view. (B) BLINC labeling of mixed HEK-neuron cultures. HEK cells
expressing BirA272-NRX3b and a dsRed marker (shown in blue) were plated on top of rat hippocampal neurons transfected with lipofectamine at
DIV10 with 3xAP-NLG1 plus a Venus marker (shown in green). Labeling was performed at DIV11 as in (A). BLINC signal could be detected in 22 out of
30 fields of view, and was localized to contact sites (arrow heads). The bottom row shows a control with a D137A mutation in NRX3b; BLINC signal
was not observed in any field of view. All scale bars, 10 mm.
doi:10.1371/journal.pone.0052823.g003
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.200 mM [28]. We opted for the high affinity sequence because
we predicted that the lower effective protein concentrations in a
trans-cellular experiment would render PRIME still interaction-
dependent – just as we observed BLINC to be interaction-
dependent with regular AP (KM of 25 mM [31]) (Figure 2B) even
though a modified, lower-affinity AP(-3) peptide was previously
necessary for interaction-dependent biotinylation by BirA in the
cytosol [32]. Third, we considered which of many PRIME probes
to use for trans-interaction readout at the cell surface. We selected
the natural substrate lipoic acid (Figure 1B) and picolyl azide
(Figure 1C). The former, detectable by antibody-fluorophore
conjugates, is advantageous for its superior ligation kinetics
compared to unnatural substrates [24,25,27]. The latter is
attractive because detection of the picolyl azide is performed
entirely with small-molecule reagents (‘‘click’’ chemistry with
alkyne-fluorophore conjugates [7]), which have better steric access
to crowded cellular junctions, do not induce crosslinking, and
minimize perturbation to the subsequent trafficking and internal-
ization of labeled proteins compared to detection by antibodies or
streptavidin.
ID-PRIME in HEK Cells
Three tandem LAP tags (3xLAP) were introduced onto the
N-terminus of NLG1, while the 38 kD LplA mutant with
improved activity in the secretory pathway (mutations: W37A,
T57I, F147L, H267R [29], referred to below as *LplA) was
fused to the N-terminus of NRX3b after amino acid 36. Lipoic
acid ID-PRIME was successfully performed in HEK cultures,
with antibody signal detected between transfected cells
(Figure 4A). Negative controls with lipoic acid omitted or the
LAP tag replaced by AP produced no signal. Like BLINC, ID-
PRIME labeling was interaction-dependent because a NRX3b
D137A mutation in the *LplA36-NRX3b construct eliminated
labeling (Figure 4A, bottom row).
Picolyl azide ID-PRIME using these same fusion constructs was
also successfully performed in HEK cultures (Figure 4B). Again,
negative controls with azide omitted, LAP replaced by AP, or a
D137A mutation in NRX3b showed no signal. Here, the ID-
PRIME signal (from Alexa Fluor 647-alkyne) was more clearly
concentrated at junctions between LplA- and LAP-expressing
cells. This is probably because the small molecule detection
reagents for picolyl azide ID-PRIME could better access the
crowded adhesion junctions compared to antibody detection
reagents used for lipoic acid ID-PRIME.
We also compared 1xLAP-NLG1 to 3xLAP-NLG1 for lipoic
acid ID-PRIME and found that the tandem LAPs did not boost
signal as strikingly as tandem APs did (data not shown), possibly
because the 3xLAP tag reduced NLG1 expression at the surface
(compared to 1xLAP), or because tandem lipoic acid molecules in
close proximity could not be simultaneously accessed by antibod-
ies.
Lipoic Acid ID-PRIME in Neurons
We proceeded to test labeling in neuron cultures. Using the
same nucleofection protocol developed for BLINC, lipoic acid ID-
PRIME signal was detected at overlap sites between neurons
expressing *LplA36-NRX3b and neurons expressing 1xLAP-
NLG1 (Figure 5A). Controls with lipoic acid omitted, LAP
replaced by AP, or a D137A mutation in NRX eliminated the
signal. In contrast to BLINC, ID-PRIME signal was localized to
overlapping sites and did not appear to spread outward on the
LAP-expressing neuron. We believe this is because the LplA-
NRX:LAP-NLG stoichiometry was better matched than the BirA-
NRX:AP-NLG stoichiometry in these neuron experiments. This is
supported by the observation that *LplA36-NRX3b surface
expression in neurons after nucleofection was much higher than
surface expression of our best BLINC construct, BirA272-NRX3b,
under identical conditions (Figure S7). This higher expression also
helps to explain why lipoic acid ID-PRIME labeling was much
more robust and reproducible than BLINC labeling in neurons.
We quantified the sensitivity of lipoic acid ID-PRIME in
neurons and found that 38–54% of contact sites between
transfected neurons (defined by the intersection of fluorescent
protein transfection markers for *LplA36-NRX3b and 1xLAP-
NLG) contained ID-PRIME signal. The lack of signal at ,46% of
contacts could be due to sensitivity limits of the methodology, or
an absence of true NRX-NLG interactions at fluorescent marker
intersection sites. Like in our neuron BLINC experiments, ID-
PRIME constructs also induced ‘‘zipping’’ of neuronal processes
(Figure 5A, marked sites in rows 1 and 2) when overexpressed.
Lipoic acid ID-PRIME also detected the trans-cellular interac-
tion between 3xLAP-NLG1 expressed in neurons and *LplA36-
NRX3b expressed in overlaid HEK cells (Figure 5B). A D137A
mutation in NRX eliminated ID-PRIME signal in this mixed
culture configuration.
To introduce reporter plasmids into separate pools of neurons
by nucleofection is labor intensive and consumes large numbers of
neurons. Lipofection of plated neurons [33] is much simpler and
uses fewer cells, so we also attempted lipoic acid ID-PRIME using
this strategy. Since lipofection usually transfects a somewhat
random and small subset of neurons, and the lipofecting medium
can be removed within hours of addition, we surmised that it
would be possible, by sequential lipofection, to generate a culture
in which some neurons express NRX only, some neurons express
NLG only, and some express both. Figure S8 shows neuron
cultures lipofected with *LplA36-NRX3b at DIV5, and again with
LAP-NLG1 one day later, at DIV6. After labeling and antibody
staining at DIV7, we detected trans signal in many fields of view
(evident from ID-PRIME signal on top of overlapping green and
blue processes), but contaminating cis signal from neurons co-
expressing both fusion constructs was also observed in some fields
of view. The cis signal was generally much stronger than the trans
signal, and spread over the entire surface of the transfected
neuron, instead of being localized to green-blue overlap sites. We
conclude that this experimental configuration is useful and much
Figure 4. ID-PRIME for imaging neurexin-neuroligin interactions in HEK cells. (A) ID-PRIME with lipoic acid readout (as in Figure 1B). HEK
cells were separately transfected with *LplA36-NRX3b plus a membrane-localized tdTomato marker (shown in blue), or 3xLAP-NLG1 plus a Venus
marker. After mixing and replating, cells were labeled with 50 mM lipoic acid +500 mM ATP for 15 minutes. Ligated lipoic acid was detected with an
anti-lipoic acid antibody followed by a secondary antibody-AF647 conjugate (shown in red) for 5 minutes each. For row 1, a magnified view
representing the boxed region, and a more contrasted view of the transfection markers are shown on the right. Controls were performed with lipoic
acid omitted (row 2), the acceptor peptide for BirA substituted for LAP (row 3), and the interaction-deficient NRX mutant (row 4). (B) ID-PRIME with
picolyl azide readout (as in Figure 1C). HEK cells were transfected as in (A), and labeling was performed with 100 mM picolyl azide +500 mM ATP for 15
minutes, followed by detection with copper-catalyzed click chemistry, using 50 mM copper and 20 mM alkyne-AF647. Color schemes and controls are
the same as for (A). All scale bars, 10 mm.
doi:10.1371/journal.pone.0052823.g004
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easier to implement, but one must be cautious about interpreting
signal as being trans or cis in origin.
Picolyl Azide ID-PRIME in Neurons
We also used sequential lipofection of plated hippocampal
neurons to test picolyl azide ID-PRIME. Figure S9A shows
fluorescent signal from the Alexa Fluor 647-alkyne (AF647-alkyne)
used for picolyl azide detection at contact sites between blue LplA-
NRX-expressing neurons and green LAP-NLG-expressing neu-
rons. A negative control with picolyl azide omitted showed no
labeling. The trans picolyl azide ID-PRIME signal was also
localized to contact sites, but was weak – considerably weaker than
Figure 5. ID-PRIME for imaging neurexin-neuroligin interactions in neuron cultures and in HEK-neuron mixed cultures. (A) Lipoic acid
ID-PRIME labeling of pure neuron cultures. Dissociated rat hippocampal neurons were separately nucleofected at DIV0 with either 1xLAP-NLG1 plus a
Venus transfection marker (shown in green), or *LplA36-NRX3b plus a membrane-localized tdTomato transfection marker (shown in blue). The two
pools of neurons were mixed and plated. At DIV5, neurons were labeled with lipoic acid and anti-lipoic acid antibody as in Figure 4A. ID-PRIME signal
was detected in 22 out of 23 fields of view, and was localized to contact sites (arrow heads, row 1). Negative controls with lipoic acid omitted (row 2),
AP-NLG1 in place of LAP-NLG (row 3), or with an interaction deficient mutant of NRX (row 4) are also shown. Asterisks in row 1 and 2 indicate sites
where the over-expression of ID-PRIME constructs caused neuronal processes to ‘‘zip up’’. (B) Lipoic acid ID-PRIME labeling of mixed HEK-neuron
cultures. HEK cells expressing *LplA36-NRX3b and a membrane-localized tdTomato marker (shown in blue) were plated on top of neurons, transfected
with lipofectamine at DIV 7 with 3xLAP-NLG1 plus a Venus marker (shown in green). Labeling was performed as in Figure 4A, at DIV8. ID-PRIME signal
was detected in 9 out of 11 fields of view in which Venus-expressing neurons contacted Tomato-expressing HEK cells. The bottom row shows a
control with a D137A mutation in NRX; no ID-PRIME signal was observed in any field of view. All scale bars, 10 mm.
doi:10.1371/journal.pone.0052823.g005
Imaging Neurexin-Neuroligin Interactions
PLOS ONE | www.plosone.org 10 February 2013 | Volume 8 | Issue 2 | e52823
lipoic acid ID-PRIME signal with the same reporter constructs,
perhaps because the two-tiered antibody detection of lipoic acid
offers signal amplification. Accordingly, we were unable to detect
picolyl azide ID-PRIME signal in nucleofected neurons which
express the reporters at lower levels than lipofected neurons (data
not shown).
Since the fusion site of BirA in NRX3b influenced the efficiency
of BLINC, we also prepared a stalk-domain fusion of *LplA in
NRX3b at the same site as BirA, (*LplA272-NRX3b) and tested
this construct for picolyl azide ID-PRIME in lipofected neurons.
Figure S9B shows that *LplA36-NRX3b and *LplA272-NRX3b
gave comparable ID-PRIME signals, suggesting that ID-PRIME is
less sensitive to the fusion geometry of *LplA, possibly because
both fusion constructs were expressed more abundantly than any
BirA-NRX3b construct in neurons.
Discussion
In summary, our work presents three findings: (1) The BLINC
methodology introduced in previous work [5] (paper now
retracted) could be reproduced in HEK cells, but not in neuron
cultures using the constructs and protocols previously described.
(2) By re-designing the NRX and NLG fusion constructs and
modifying the labeling protocol, we were able to achieve BLINC
labeling in neuron cultures. (3) Due to poor surface expression of
BirA fusion constructs, our new BLINC protocol was still not
robust in neurons, so we developed ID-PRIME for detection of
trans-cellular NRX-NLG interactions. ID-PRIME was much
more robust than BLINC in neuron cultures and the signal could
be read out by either antibodies or small-molecule reagents.
Regarding the first point, the reasons for the lack of
reproducibility of BLINC in neurons that we observed were: (i)
the CMV promoter plasmids used previously [5], when introduced
at DIV0 by nucleofection, expressed only transiently and could not
be detected by DIV5. All previously reported experiments were
performed in neurons at DIV5 and DIV16 [5], when BLINC
reporters were no longer present. (ii) Even after changing the
promoter from CMV to CAG to obtain persistent expression after
nucleofection, the 1xAP tag on NLG1 was barely detectable above
background. (iii) BirA inserted near the N-terminus of the mature
NRX, as in the previous study [5], did not give detectable BLINC
signal in neurons, even when the CAG promoter and a 3xAP-
NLG1 were used. (iv) Use of biotin-AMP gave high background
signal in neuron BLINC experiments. This reagent was used in all
experiments in the previous study [5].
Here, we achieved BLINC labeling in neuron cultures by
driving persistent expression with CAG promoters, installing 3xAP
in place of 1xAP on NLG, moving BirA to the stalk domain of
NRX, and using biotin+ATP instead of biotin-AMP. Nevertheless,
we found that BLINC in neurons was not robust and sometimes
failed, likely due to poor surface targeting of even our best BirA-
NRX fusion. It is, however, a strength of the labeling system that
such low, virtually non-detectable levels of surface BirA expression
could produce detectable BLINC signal, attesting to the high
sensitivity of streptavidin-fluorophore detection. Engineering of
the BirA sequence or exploration of alternative fusion sites may
improve surface BirA expression in future reporter designs.
In contrast to neurons, BLINC in non-neuronal cells (e.g.,
HEK) and in mixed neuron-HEK cultures, which comparatively
exhibit higher surface expression of BirA constructs, was very
reliable and specific. The signal was also interaction-dependent,
and well-localized to cell-cell contact sites, and should therefore be
a useful method with which to detect and image other trans-
cellular protein-protein interactions.
Lastly, we introduce in this study a new methodology for
imaging trans-cellular protein complexes using interaction-depen-
dent PRIME (ID-PRIME). In ID-PRIME, an LplA mutant
replaces BirA, and LAP replaces AP. The advantages of ID-
PRIME over BLINC are two-fold: (1) The *LplA-NRX fusion has
much better surface targeting than BirA-NRX (despite its slightly
larger size of 38 kD), leading to robust and reproducible signal in
neuron cultures that is localized to NRX-NLG contact sites. (2)
Using the picolyl azide detection strategy [7] (Figure 1C), NRX-
NLG interactions can be read out with small, bright fluorophores
that are less likely to introduce trafficking artifacts or be sterically
excluded from crowded synaptic regions compared to the
streptavidin reagent used for BLINC. This work demonstrated
ID-PRIME in three experimental configurations: HEK cultures
(Figure 4), mixed HEK-neuron cultures (Figure 5B), and neuron
cultures (Figure 5A). Given its advantages over BLINC, ID-
PRIME expands the toolkit available for imaging trans-cellular
protein-protein interactions in living cells.
There are still some issues to be resolved, however, before ID-
PRIME can be a minimally-invasive and faithful tool with which
to study physiologically relevant NRX-NLG interactions in
neurons. The major concern is that its sensitivity must be
improved to the point that signal can be easily detected even
when reporter constructs are not overexpressed. This is particu-
larly true for picolyl azide ID-PRIME, which currently has lower
sensitivity than lipoic acid ID-PRIME in neurons even though its
reagents are more suitable for reporting on synaptic protein
complexes. A second concern is that we did not examine the effects
of neurexin and neuroligin shedding on BLINC or ID-PRIME
signal in this work. Recent studies have shown that the
ectodomains of both NRX [34,35] and NLG [36,37] may be
cleaved by membrane-anchored metalloproteases in a potentially
activity-dependent manner. This could complicate the interpreta-
tion of BLINC and ID-PRIME data if some fusion constructs of
NRX and NLG are more prone to cleavage than wild-type (giving
false negatives), or if labeling signal on the cleaved NLG
ectodomain that ought to have escaped into the medium is
trapped by full-length NRX (giving false positives). We plan to
study and address these limitations in future work.
Supporting Information
Figure S1 Expression of CMV-AP-NLG1 from reference [5]
cannot be detected in neurons, but CAG promoter constructs can
be detected. The indicated plasmids were introduced by
nucleofection, along with a Venus marker (shown in green), into
DIV0 dissociated rat hippocampal neurons. At either DIV5 (left),
or DIV12 (right), surface AP fusion proteins were labeled with
1 uM exogenous BirA (+ biotin and ATP), followed by
streptavidin-AF647 (shown in red), then imaged live. Streptavidin
channel intensities are normalized within the DIV5 dataset and
within the DIV12 dataset, but not across datasets. Labeling of
CMV-1xAP-NLG1 was not detected across 10 transfected cells at
DIV5, and 23 transfected cells at DIV12. Labeling of CAG-1xAP-
NLG1 was detectable but weak in 4 of 10 transfected cells at
DIV5, and 12 of 23 transfected cells at DIV12. Labeling of CAG-
3xAP-NLG1 (with three AP tags in tandem) was generally
stronger, and detected in 8 of 9 neurons at DIV5, and 12 of 16
transfected neurons at DIV12. On the right, the arrowhead points
to a lightly streptavidin-labeled cell that expressed the Venus
marker weakly. Scale bars, 10 mm.
(TIF)
Figure S2 Expression of CMV-BirA64-NRX1b from reference
[5] cannot be detected in neurons after nucleofection. The CMV-
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BirA64-NRX1b plasmid was introduced by nucleofection, along
with a Venus marker (shown in green), into DIV0 dissociated rat
hippocampal neurons. Anti-c-Myc staining was performed on
living cells to detect surface expression of the BirA-NRX at DIV5
(top) and DIV12 (bottom). As a positive control, staining was
performed in parallel on neurons transfected with the same
plasmid, using lipofectamine instead of nucleofection, 1 day before
the labeling experiment. In general, we find that lipofection of a
plasmid gives much higher expression in neurons than nucleofec-
tion of the same plasmid. AF647 channel intensities are
normalized within DIV5 and DIV12 datasets, but not across
datasets. For samples nucleofected with CMV-BirA64-NRX1b
following the protocol in reference [5], c-Myc staining could not be
detected across 13 transfected cells at DIV5 and 16 transfected
cells at DIV12. For lipofected control samples, c-Myc staining
could be detected in 4 of 5 cells at DIV5, and 4 of 7 cells at DIV12.
In general, c-Myc staining on lipofected neurons was weaker at
DIV12 than at DIV5 in this experiment. Scale bars, 10 mm.
(TIF)
Figure S3 The CAG promoter gives more persistent expression
of BirA64-NRX1b in neurons than the CMV promoter. BirA64-
NRX1b with either a CMV or CAG promoter was introduced to
plated hippocampal neurons at DIV5 using lipofectamine, along
with a synaptophysin-YFP marker (shown in green). Expression
was detected 4 days later, at DIV9, by anti-c-Myc staining on
either living neurons (top) or fixed and permeabilized neurons
(bottom). c-Myc staining background was very high for fixed
neurons. Whereas CMV-BirA64-NRX1b expression could not be
detected across multiple fields of view, CAG-BirA64-NRX1b
expression was detectable 4 days after lipofection. Note that in
Figure S2, lipofected CMV-BirA64-NRX1b was detected 1 day
rather than 4 days after lipofection. Scale bars, 10 mm.
(TIF)
Figure S4 Trafficking of BirA fusion constructs in HEK and
neurons. (A) Domain structures of BirA and AP fusions to
NRX3b, NRX1b, and NLG1 used in this figure. Construct
numbering according to Table S1 is given at right. TM is the
transmembrane domain. (B) BirA and AP insertion sites in NRX
and NLG. A side-on view into the synaptic cleft is shown for the
dimeric extracellular domain of NLG1 (amino acids 52-634) in
complex with two extracellular domains of NRX1b (amino acids
82-288; colored orange). From PDB 3VKF [38]. Ca2+ ions are
shown in green. Note that amino acid 288 of NRX1b corresponds
to amino acid 259 of NRX3b. (C) Trafficking in HEK cells. Cells
were transfected with the indicated constructs, fixed and
permeabilized, then stained with the indicated antibodies.
Fluorescence images are not normalized. Bottom row shows
overlay onto DIC images. The BirA tag reduces surface trafficking
of NRX1b, NRX3b, and NLG1. (D) Trafficking in neurons.
Hippocampal neurons were lipofected at DIV11 with the
indicated constructs and a Venus co-transfection marker (shown
in green). One day later, neurons were stained live with anti-HA
antibody to visualize surface expression. (E) Same as (D) except
that neurons were fixed and permeabilized before staining with
anti-HA antibody to visualize total protein pools, rather than
surface pools only. Trafficking of NRX3b and NLG1 to processes
is impaired when either is fused to BirA. Scale bars, 10 mm.
(TIF)
Figure S5 Synaptic localization of optimized BLINC constructs
in neurons. Hippocampal neurons were lipofected with the
indicated constructs and synaptic markers at DIV11 and imaged
live at DIV12. The pre-synaptic marker synaptophysin-YFP was
used at left, and the post-synaptic marker Homer-GFP was used at
right, both shown in green. Anti-HA staining was performed on
living neurons to visualize surface pools of BirA (left) and AP (right)
fusion proteins. In the ‘‘merge’’ panel, yellow indicates sites of red-
green overlap. All scale bars, 10 mm.
(TIF)
Figure S6 Use of biotin-AMP for BLINC in neuron cultures
generates high imaging background. Hippocampal neurons were
nucleofected at DIV0 with BirA272-NRX3b plus dsRed (shown in
blue), or 3xAP-NLG1 plus Venus (shown in green). The two pools
were mixed together and allowed to form contacts. At DIV9, cells
were labeled with biotin+ATP, or biotin-AMP ester, as indicated
for 5 minutes, then stained with monovalent streptavidin-AF647
(shown in red) for another 5 minutes and imaged live. On the right
are images of untreated coverslips. From this experiment we
conclude that signal intensities are similar for biotin+ATP, and
2.5 uM biotin-AMP. However, the nonspecific background is
higher when using 2.5 uM biotin-AMP. In contrast, the
background when using biotin+ATP is the same as for untreated
coverslips, i.e., undetectable. Note that the problem of high
background with biotin-AMP is observed only for neurons, and is
not seen when performing BLINC or exogenous BirA labeling on
HEK cells (as in Figure 2B). Scale bars, 10 mm.
(TIF)
Figure S7 Comparison of surface trafficking in neurons for
BLINC and ID-PRIME ligase fusion constructs. (A) Domain
structures of LplA, BirA, and LAP fusion constructs used in this
figure and Figures S8 & S9. Construct numbering according to
Table S1 is given at right. TM is the transmembrane domain. HA
tags are colored red and a linker is colored green. (B) Comparison
of surface trafficking in neurons for BLINC and ID-PRIME ligase
fusion constructs. Hippocampal neurons were nucleofected at
DIV0 with *LplA36-NRX3b or BirA272-NRX3b, plus a mem-
brane tdTomato marker (shown in green). At DIV5, surface
expression of each construct was detected by live-cell immuno-
staining with anti-HA antibody, shown in red at two different
intensity levels. *LplA36-NRX3b surface expression was easily
detected in 19 out of 19 transfected neurons, while BirA272-
NRX3b surface expression was undetectable in 10 out of 10
transfected neurons. Note that in Figure S4D, surface detection of
BirA272-NRX3b was performed after lipofection, not nucleofec-
tion. Scale bars, 10 mm.
(TIF)
Figure S8 Lipoic acid ID-PRIME with lipofected neuron
cultures. Same as Figure 5A, except that constructs were
introduced by sequential lipofection into plated hippocampal
neurons at DIV5 and DIV6, instead of by nucleofection into
separate pools of DIV0 neurons (which ensures complete plasmid
segregation). For lipofection, *LplA36-NRX3b plus a membrane
tdTomato marker (shown in blue) were first introduced at DIV5,
then the same cultures were lipofected again at DIV6 with 1xLAP-
NLG1 plus a Venus marker (shown in green). All constructs had
CAG promoters. At DIV7, lipoic acid ID-PRIME labeling was
performed as in Figure 4A. Expression of *LplA-NRX and
1xLAP-NLG in the same neuron (indicated by overlap of green
and blue markers) resulted in diffuse cis ID-PRIME signal (row 1)
much stronger than the trans-cellular ID-PRIME signal (row 2) in
the same dish. Trans-cellular ID-PRIME signal was always
localized to contact sites (arrow heads). Omission of lipoic acid
suppressed both cis (row 3) and trans (row 4) ID-PRIME signal.
Scale bars, 10 mm.
(TIF)
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Figure S9 Picolyl azide ID-PRIME in lipofected neuron
cultures. (A) Same as Figure S8, but with picolyl azide rather
than lipoic acid readout. Neurons were transfected with two
sequential rounds of lipofection at DIV5 and DIV6. As a result,
some neurons express *LplA36-NRX3b with a membrane td-
Tomato marker, some express 1xLAP-NLG1 with a Venus
marker, and some express all four plasmids. Picolyl azide labeling
was performed live with 100 mM picolyl azide +500 mM ATP for
20 minutes. Neurons were then fixed, and ligated azide was
detected with 1 mM CuSO4 and 5 mM alkyne-AF647 for 1 hour.
(B) Geometry-independence of ID-PRIME signal in neurons.
Neurons were transfected as in (A) with two sequential rounds of
lipofection at DIV7 and DIV8. In the top row, *LplA36-NRX3b
(N-terminal fusion construct) was used, while in the bottom row,
*LplA272-NRX3b (stalk fusion construct) was used. Labeling with
picolyl azide and alkyne-AF647 was performed as in (A). Scale
bars, 10 mm.
(TIF)
Table S1 Genetic constructs used in this work.
(TIF)
Methods S1 Supporting materials and methods.
(DOCX)
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